Louise Kearney, MSc

Louise Kearney is Head of Rare Disease, Pediatrics and Cell & Gene Therapy Strategy and Delivery at Fortrea. She has 25 years of experience across sites, biotech, pharmaceutical, and CRO companies. She has worked at Fortrea for 21 years, including 10 years in Project Management and 8 years as part of the Rare Disease, Advanced Therapies, and Pediatric team, where she established best practices for these complex studies. Her current role combines strategic leadership and delivery accountability for programs across the therapeutic areas within this portfolio at Fortrea. Louise acts as the central point of coordination for all CGT-related activities and workstreams.